Daniella Beckman - Insider Trading & Ownership

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., One Kendall Square, Bldg. 1400, Cambridge, MA
Summary
The estimated net worth of Daniella Beckman is at least $2.81M dollars as of June 14, 2024. Daniella Beckman is the Chief Financial Officer of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $1.67M. Daniella Beckman is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $1.14M.
All Insider Reports
All Insider Reports

Ownership of Daniella Beckman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TNGX Tango Therapeutics, Inc. Chief Financial Officer $1.67M -$46.9K -2.73% Feb 6, 2024
BPMC Blueprint Medicines Corp Director $1.14M Jun 12, 2024
TBIO Translate Bio, Inc. Director Sep 14, 2021
VOR Vor Biopharma Inc. Director May 23, 2024

Insider Transactions Reported by Daniella Beckman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.